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Abstract
Background: Among human Salmonella Enteritidis infections, phage type 4 has been the dominant
phage type in most countries in Western Europe during the last years. This is reflected in Salmonella
infections among Swedish travellers returning from abroad. However, there are differences in
phage type distribution between the countries, and this has also changed over time.
Methods: We used data from the Swedish infectious disease register and the national reference
laboratory to describe phage type distribution of Salmonella  Enteritidis infections in Swedish
travellers from 1997 to 2002, and have compared this with national studies conducted in the
countries visited.
Results: Infections among Swedish travellers correlate well with national studies conducted in the
countries visited. In 2001 a change in phage type distribution in S. Enteritidis infections among
Swedish travellers returning from some countries in southern Europe was observed, and a
previously rare phage type (PT 14b) became one of the most commonly diagnosed that year,
continuing into 2002 and 2003.
Conclusions: Surveillance of infections among returning travellers can be helpful in detecting
emerging infections and outbreaks in tourist destinations. The information needs to be
communicated rapidly to all affected countries in order to expedite the implementation of
appropriate investigations and preventive measures.
Background
Salmonella Enteritidis is the most common serovar causing
food-borne salmonellosis in humans, causing approxi-
mately 80% of salmonellosis cases reported in Europe [1].
During the 80s and early 90s, a steady increase in S. Enter-
itidis infections was reported in Europe and North Amer-
ica [2-4]. The most common phage types of S. Enteritidis
varies between countries; while phage type (PT) 4 is
reported to be dominant in most countries in Western
Europe, PT 8 is common in North America and also a few
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European countries [5-7]. Epidemiological and environ-
mental studies have implicated eggs and poultry products
as primary risk factors for infection [3,8]. Approximately
70% of outbreaks caused by S. Enteritidis in Europe dur-
ing the 90s, were related to eggs and egg products [1].
Based on these findings, prevention and control measures
in the egg and poultry industry have been implemented in
the European Union and in the US [9,10]. These measures
seem to have been effective in reducing S. Enteritidis con-
tamination of eggs [11] and are believed to have lead to a
decrease in human incidence of S. Enteritidis in recent
years [1,9,12].
In Sweden, about 85% of the reported salmonella infec-
tions are acquired during travel abroad and the levels in
domestic animals and food products is low [13]. There-
fore, trends in human salmonellosis in Sweden have
mainly reflected trends in foreign travel and countries
with popular package tour resorts account for the majority
of infections.
In this study, we investigate trends in travel related S.
Enteritidis infections, describe the phage type distribution
of S. Enteritidis isolated from Swedish travellers returning
from abroad related to country of infection, and discuss
possible reasons for the emergence of a new phage type of
S. Enteritidis in 2001. A preliminary analysis of a subset of
these data was published as a short letter in the Lancet in
2002 [14].
Methods
In Sweden, salmonellosis is a mandatory notifiable dis-
ease. Both clinicians and laboratories are required to
report a case to the infectious disease register at the Swed-
ish Institute for Infectious Disease Control (SMI). Based
on the patient's travel history, information on probable
country of infection is collected on the notification forms.
Diagnosis of salmonella infections is made at regional
microbiology laboratories, and all isolates are submitted
to the national reference laboratory at SMI for serotyping
and phage typing. In this study we have included all cases
of  S.Enteritidis notified to SMI from January 1, 1997
through December 31, 2002.
To investigate trends in travel-related infections, we col-
lected information on air travel from the Swedish Civil
Aviation Administration (CAA)[15]. The figures include
all passengers carried on flights from any CAA airport to
their first foreign destination, without indicating whether
this destination is for transfer or the final destination.
Using these figures as denominators, we calculated annual
incidence rates for countries reported as place of infection
for the three most popular countries for charter tourism
among Swedes – Spain, Greece and Turkey. The incidence
rates were calculated by dividing the number of cases
reported as infected in the respective countries by number
of flight passengers to that country.
For the geographical description of dominant phage types
in the different countries the analysis was restricted to
infections acquired in countries in Europe during 1997 to
2002, and to countries from which more than ten cases
were reported during this period. A phage type was con-
sidered dominant if it represented >30% of the isolates
and was at least twice as common as the second most
common phage type. If none of the phage types fulfilled
these criteria, the two most common phage types that
together represented >50% of the cases were defined as
the dominant types. The pattern for 1997 to 2000 was
compared with the pattern for 2001.
Results
Of 13,271 cases of S.Enteritidis infections notified during
1997–2002, 11,570 cases (87%) were reported as infected
abroad, 1,032 (8%) were reported as infected in Sweden,
and information of probable country of infection was not
available for 669 (5 %). The total number of cases
reported each year varied from 1,598 to 2,629 cases, with
the highest being reported in 1999 and the lowest in
2002. Imported cases varied between 1,404 and 2,164.
The most common countries of infection during the six-
year period were Spain, Greece and Turkey, accounting for
34%, 8% and 4% of all cases, respectively.
For six countries – 'Spain, Greece, Turkey, Poland, Thai-
land and Portugal – >50 cases of infection with S. Enteri-
tidis among Swedish travellers were reported each year
during 1997 to 2002. These are all popular destinations
for leisure travel among Swedes. Figure 1 presents inci-
dence rates for the three most popular countries for char-
ter tourism, Spain, Greece and Turkey, using the number
of flight passengers from Sweden to the first foreign desti-
nation as the denominator. The figure shows that the inci-
dence rate among travellers to Spain and Turkey seemed
to decrease during the six-year period, while for Greece the
incidence peaked in 2001.
Eighty-six percent (10,049) of the isolates from 1997 to
2001 were phage-typed, increasing from 75% in 1997 to
95% in 2001. The most common phage types over the
period were PT 4 and PT 1 (Figure 2), accounting for 35%
and 16% of all cases, respectively. In travellers returning
from most countries in Western Europe, PT 4 was the
dominant phage type. In Eastern Europe, PT 1 was domi-
nant, and this phage type was also common among trav-
ellers returning from the Iberian Peninsula. PT 8 seemed
to be more common among travellers returning from cen-
tral European countries.BMC Medicine 2004, 2:32 http://www.biomedcentral.com/1741-7015/2/32
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In 2001 this pattern changed when PT 14b increased
among travellers from several countries in Southern
Europe (Figure 3b). PT 14b was the third most common
phage type among returning travellers in 2001, account-
ing for 13% of all isolates that were phage-typed that year
(272/2,132), compared with 2 % of all that were phage-
typed in the previous four years (154/7,917). This trend
continued into 2002 when PT14b accounted for 9% (134/
1,489) of all typed isolates. The majority of the PT 14b
cases in 2001 and 2002 were reported among travellers
returning from Greece (Figure 4), and this phage type
accounted for 54%(157/293), 47%(83/176) and
42%(50/117) of all cases of S. Enteritidis from Greece in
2001, 2002 and 2003, respectively.
Discussion
We have described trends and phage type distribution of
S. Enteritidis isolates among Swedish travellers infected
abroad. Phage type 4 was the dominant phage type
among returning travellers. There were, however, some
differences in distribution between the countries and with
time. Between 1997 and 2000, PT 1 dominated among
travellers returning from Russia and the Baltic countries,
PT 8 was commonly seen among travellers returning from
some central European countries, and PT 4 dominated
among travellers returning from most other European
countries (Figure 3). In 2001 a change in phage type dis-
tribution was observed among Swedish travellers return-
ing from some countries in South-Eastern Europe. PT 14b,
a previously rare phage type, appeared to become pre-
dominant among travellers returning from Greece and
also became more common among travellers from some
other countries.
During the six-year period, the S. Enteritidis incidence rate
among travellers to Spain and Turkey appeared to decline.
This trend is in contrast to surveillance data from Spain,
which seem to show an increasing incidence over the
same period [16]. The reason for this declining trend
among tourists was not investigated, but may be related to
an increased awareness among tourists concerning the
prevention of traveller's diarrhoea or to improved food
control efforts in some of the popular tourist resorts.
There are some uncertainties when calculating incidence
rates based on number of travellers. The number of travel-
lers used as the denominator in the incidence rate calcula-
tions is based on the statistics of the airport of first landing
after leaving Sweden. If the first airport is not the final des-
tination, these travellers will not be included in the
denominator for the destination country. Thus the calcu-
lated incidence rates for transit countries will be too low,
while the incidence rates for the final destination coun-
tries will be too high.
When comparing S. Enteritidis phage types isolated from
Swedish travellers with studies conducted in the countries
visited, isolates found in travellers were generally consist-
ent with the dominant strains reported among inhabit-
ants in the respective countries. Table 1 summarises the
Incidence rates (IR) of Salmonella Enteritidis infections among  Swedish travellers to Spain, Greece and Turkey Figure 1
Incidence rates (IR) of Salmonella Enteritidis infections among 
Swedish travellers to Spain, Greece and Turkey. Country 
specific annual incidence rate of Salmonella Enteritidis per 
100,000 air travellers from Sweden. Incidence rates are cal-
culated based on the number of cases notified to the Swedish 
infectious Disease register using the number of flight passen-
gers from Sweden to the first foreign destination as the 
denominator.
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Distribution of phage types of Salmonella Enteritidis cases  notified in Sweden, 1997 to 2002 Figure 2
Distribution of phage types of Salmonella Enteritidis cases 
notified in Sweden, 1997 to 2002.
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Dominant phage types of Salmonella Enteritidis infections among Swedish travellers according to country visited Figure 3
Dominant phage types of Salmonella Enteritidis infections among Swedish travellers according to country visited. Only coun-
tries with more than 10 reported cases and phage types accounting for > 25 % of all cases are shown. a) 1997 – 2000 b) 2001
A
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results of published studies on salmonellosis from a
number of countries. The percentages of PT 4 and PT 6
among human S. Enteritidis infections in Austria and
Denmark, respectively, have been reported to be
decreasing in the last years [6]. These same trends were
reflected among returning Swedish travellers.
People returning from travel abroad may have a higher
tendency to seek medical care and have a stool sample
taken if an imported infection is suspected. In addition,
visitors may be more susceptible to pathogens circulating
in the community than the local inhabitants. The detec-
tion of new, emerging strains in travellers after returning
to their home countries may therefore be helpful in
detecting changes in the pathogen reservoir occurring in
the countries visited, especially in tourist destinations.
However, tourists have a tendency to aggregate in some
smaller resorts that may have a different pathogen reser-
voir and rely on food supplies that are different from the
rest of the country. This may lead to differences in risks
and pathogens between the inhabitants and the tourists
visiting the country that needs to be taken into
consideration.
The change in phage type distribution observed among
Swedish travellers returning from some countries in
Southern Europe in 2001 was not observed among inhab-
itants in the countries visited. In total, the two most com-
mon phage types among Swedish travellers were, as in
previous years, PT 4 and PT 1. However, the third most
common was PT 14b, a phage type hitherto uncommon
in Sweden with only 20 to 40 cases reported annually
prior to 2001. The majority of the cases were among trav-
ellers returning from Greece (90%). More cases were also
reported among travellers returning from Spain and Bul-
garia than in previous years. During the same time period,
an increase in the same phage type had also been regis-
tered among Norwegian and Finnish travellers returning
from Greece [17]. A request on Enter-Net (European
network for the surveillance of enteric infections – Salmo-
nella  and VTEC O157) sent by the Norwegian Public
Health Institute gave no response on increases of PT 14b
in other countries. Spain reported an outbreak of the same
phage in a school in January (unpublished data). But after
this event, no further increase was noted. The UK later
reported an increased number of the same phage type,
both among travellers and among people who had been
infected in the UK. However, there the 14b isolates of
domestic origin were aerogenic, while isolates associated
with travel to Greece were predominantly anaerogenic
[18]. The isolates among Swedish travellers returning
from Greece were also predominantly anaerogenic.
No explanation for the sudden increase in this phage type
among Nordic travellers to different countries in Southern
Europe has been found. PT 14b is not a new phage type
and outbreaks reported previously have been mainly
related to eggs and egg-products (ice-cream, tiramisu
[19,20]) or improper hygiene practices [21,22]. However,
these outbreaks were localised, of limited duration, and
the incriminated food products found and the outbreaks
contained. The cause of the increase of this phage type
among Nordic travellers in 2001 is still unclear. It may
represent a geographically more widespread outbreak
than previously described, possibly due to increased trade
in food products, animals or animal feed across the bor-
ders. Another possible explanation for this increase may
be that changes in PT 14b could have contributed to
increased resistance or virulence factors, thereby
facilitating the spread of this phage type in the environ-
ment. Alternatively, acquisition or loss of a plasmid or
spontaneous mutations may have resulted in a conversion
from another phage type to PT 14b. Such change has been
described for other phage types [23-25] and a conversion
from PT 8 to PT 14b has been described after inoculation
into pathogen-free chicken [26].
Our data presented are limited by the small numbers of
cases from each country investigated on an annual basis.
It is therefore difficult to evaluate trends with any cer-
tainty. However, the possibility of using surveillance data
of infections among returning travellers to detect emerg-
ing pathogens should be further investigated. In addition,
data from countries that routinely collect information on
travel could be pooled in order to increase the numbers of
travel-related infections. In several countries outside
Europe, laboratory capacity is limited and it may take a
long time to detect the emergence of new pathogens or
Notified cases of Salmonella Enteritidis PT 14b among Swed- ish travellers by country of infection, 1997 – 2002 Figure 4
Notified cases of Salmonella Enteritidis PT 14b among Swed-
ish travellers by country of infection, 1997 – 2002.
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subtypes. Not all countries in Europe collect information
on the probable place of infection and phage typing of
Salmonella  isolates is not routinely performed in some
countries. However, if available, this information will be
included in the data reported to Enter-Net. Data from this
network has previously been useful in detecting travel-
related outbreaks [27,28], and may also be useful in
describing pathogen patterns in countries where labora-
tory capacities are limited or routine typing is not per-
formed. Importantly, Enter-Net may expedite the
dissemination of information concerning emerging
pathogens.
Conclusions
This study demonstrates that surveillance of infections
among returning travellers may be helpful in detecting
emerging infections and outbreaks in tourist destinations,
and provides some useful supplementary data about
infectious diseases and trends in other geographical
regions. Characterization of isolates from travellers can
detect changes in the pathogen and antimicrobial resist-
ance patterns in the destination country. This information
may be an important supplement in countries where sur-
veillance systems are deficient or lacking, or where the lab-
oratories have limited capacity to do detailed sub-typing
and resistance testing. In addition, infections and out-
breaks among tourists may not always affect the local res-
Table 1: Dominant Salmonella Enteritidis phage types by country*. Comparison between findings among Swedish travellers and studies 
conducted in the countries visited.
Country Number of S. Enteritidis-
infections notified among 
Swedish travellers
1997–2001
Most common S. 
Enteritidis phage types 
among returning Swedish 
travellers
1997–2001(%*)
Predominant phage type 
described in studies from 
the country visited
Year of study Reference
Spain 4125 1 (33%), 4 (36%) 1, 4, 6 1990s [29]
Greece 1997–2000 916 4 (44%)
14b (59%)
Turkey 496 4 (65 %) 4 Not mentioned [30]
Poland 354 4 (40 %) 4, 8 1986–95 [31]
Portugal 344 1 (43 %)
Morocco 310 4 (50 %)
Germany 235 4 (59%) 4 1998 [32]
Denmark 1997–1998
1999
2000–2001
223 6 (42%), 8 (43%)
34 (73%)
4 (30%), 8(30%)
6, 8
PT34 outbreak in DK
4, 8
1997–98
1999
2000–2001
[33]
Czech Republic 194 8 (68%) 8 1989–98 [34]
Bulgaria 180 4 (55%
Cyprus 166 1 (36%), 4 (45%)
Tunisia 152 4 (75%)
Italy 152 4 (47%) 4 1990–93 [29,35]
United Kingdom 133 4 (76%) 4 1997–2000 [36]
Hungary 120 4 (50%) 4 1992–94 [37]
France 110 4 (56%)
Austria 1997–2000
2001
81 4 (52%), 8 (38%)
4 (33%), 8 (42%)
4 1995–2001 [6]
Latvia 1997–2000
2001
76 1 (63%)
1 (60%), 4 (40%)
Egypt 63 4 (55%)
Croatia 53 4 (63%)
Belgium 45 4 (72%)
Russia 42 1 (62%) 1 1980–93 [38]
Estonia 1997–2000
2001
37 1 (58%)
1 (25%), 4(75%)**
Bosnia and Herzegovina 26 4 (64%)
The Netherlands 20 4 (75%) 4 1997–2001 [6]
Slovakia 14 8 (62%) 8 1995 [39]
Lithuania 12 1 (50%)
* Calculated as a percentage of all isolates that were phage-typed during 1997–2001.
** Based on less than 10 cases.BMC Medicine 2004, 2:32 http://www.biomedcentral.com/1741-7015/2/32
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idents and therefore may not be detected by the local
public health authorities. If proper investigations, and
appropriate prevention and control measures are to be
implemented in the countries visited, it is important that
the surveillance information compiled from the traveller's
home countries is rapidly communicated to the affected
countries.
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